Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Villoslada

Showing results (11-20 of 207) with videos related to

Pageof 21
Sort By:
Progress in Brain Research|January 1, 2004
Role of nerve growth factor and other trophic factors in brain inflammationPablo Villoslada, Claude P Genain
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 2021
Aquaporin-4-neuromyelitis optica spectrum disorder is not a progressive diseasePablo Villoslada, Bernardo Sanchez-Dalmau
Brain : a Journal of Neurology|January 31, 2019
Remyelination: a good neuroprotective strategy for preventing axonal degeneration?Pablo Villoslada, Elena H Martinez-Lapiscina
Cytokine & Growth Factor Reviews|June 2, 2007
Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genesCatherine O'Doherty, Pablo Villoslada, Koen Vandenbroeck
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 21, 2017
Time is vision: The importance of the early discovery and diagnosis of optic neuritisPablo Villoslada, Elena H Martinez-Lapiscina
Neurology|March 3, 2021
Seeing the Finish Line: Can Baseline OCT Values Predict Long-term Disability and Therapeutic Management in Multiple Sclerosis?Pablo Villoslada, Steven L Galetta, Ahmed Toosy
Neurology|July 30, 2020
Optical coherence tomography: A useful tool for identifying subclinical optic neuropathy in diagnosing multiple sclerosisPablo Villoslada, Bernardo Sanchez-Dalmau, Steven Galetta
Annals of Neurology|March 5, 2009
Systems biology and its application to the understanding of neurological diseasesPablo Villoslada, Lawrence Steinman, Sergio E Baranzini
Neurology|April 21, 2019
Personalizing medical care for patients with MS: Monitoring brainstem damage by infrared oculographyPablo Villoslada, Ari J Green, Steven Galetta
Expert Opinion on Pharmacotherapy|November 14, 2008
Pharmacogenomics of multiple sclerosis: in search for a personalized therapyIván Martinez-Forero, Antonio Pelaez, Pablo Villoslada
Pageof 21

Showing results (11-20 of 207) with videos related to

Sort By:
Pageof 21
Progress in Brain Research|January 1, 2004
Role of nerve growth factor and other trophic factors in brain inflammationPablo Villoslada, Claude P Genain
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 2021
Aquaporin-4-neuromyelitis optica spectrum disorder is not a progressive diseasePablo Villoslada, Bernardo Sanchez-Dalmau
Brain : a Journal of Neurology|January 31, 2019
Remyelination: a good neuroprotective strategy for preventing axonal degeneration?Pablo Villoslada, Elena H Martinez-Lapiscina
Cytokine & Growth Factor Reviews|June 2, 2007
Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genesCatherine O'Doherty, Pablo Villoslada, Koen Vandenbroeck
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 21, 2017
Time is vision: The importance of the early discovery and diagnosis of optic neuritisPablo Villoslada, Elena H Martinez-Lapiscina
Neurology|March 3, 2021
Seeing the Finish Line: Can Baseline OCT Values Predict Long-term Disability and Therapeutic Management in Multiple Sclerosis?Pablo Villoslada, Steven L Galetta, Ahmed Toosy
Neurology|July 30, 2020
Optical coherence tomography: A useful tool for identifying subclinical optic neuropathy in diagnosing multiple sclerosisPablo Villoslada, Bernardo Sanchez-Dalmau, Steven Galetta
Annals of Neurology|March 5, 2009
Systems biology and its application to the understanding of neurological diseasesPablo Villoslada, Lawrence Steinman, Sergio E Baranzini
Neurology|April 21, 2019
Personalizing medical care for patients with MS: Monitoring brainstem damage by infrared oculographyPablo Villoslada, Ari J Green, Steven Galetta
Expert Opinion on Pharmacotherapy|November 14, 2008
Pharmacogenomics of multiple sclerosis: in search for a personalized therapyIván Martinez-Forero, Antonio Pelaez, Pablo Villoslada
Pageof 21